145 related articles for article (PubMed ID: 34260853)
21. Mapping interactions of gastric inhibitory polypeptide with GIPR N-terminus using NMR and molecular dynamics simulations.
Tikhele SH; Pissurlenkar RR; Srivastava S; Saran A; Coutinho EC
J Pept Sci; 2010 Aug; 16(8):383-91. PubMed ID: 20607844
[TBL] [Abstract][Full Text] [Related]
22. Identification of determinants of glucose-dependent insulinotropic polypeptide receptor that interact with N-terminal biologically active region of the natural ligand.
Yaqub T; Tikhonova IG; Lättig J; Magnan R; Laval M; Escrieut C; Boulègue C; Hewage C; Fourmy D
Mol Pharmacol; 2010 Apr; 77(4):547-58. PubMed ID: 20061446
[TBL] [Abstract][Full Text] [Related]
23. Activation of GIPR Exerts Analgesic and Anxiolytic-Like Effects in the Anterior Cingulate Cortex of Mice.
Wang XS; Jiang YL; Lu L; Feng B; Ma X; Zhang K; Guan SY; Yang L; Fan QY; Zhu XC; Yang F; Qi JY; Yang LK; Li XB; Zhao MG; Jiang W; Tian Z; Liu SB
Front Endocrinol (Lausanne); 2022; 13():887238. PubMed ID: 35712239
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of a rare glucose-dependent insulinotropic polypeptide receptor variant in a patient with diabetes.
Jacobi SF; Khajavi N; Kleinau G; Teumer A; Scheerer P; Homuth G; Völzke H; Wiegand S; Kühnen P; Krude H; Gong M; Raile K; Biebermann H
Diabetes Obes Metab; 2019 May; 21(5):1168-1176. PubMed ID: 30784161
[TBL] [Abstract][Full Text] [Related]
25. Glucose-dependent insulinotropic polypeptide prevents the progression of macrophage-driven atherosclerosis in diabetic apolipoprotein E-null mice.
Nogi Y; Nagashima M; Terasaki M; Nohtomi K; Watanabe T; Hirano T
PLoS One; 2012; 7(4):e35683. PubMed ID: 22536426
[TBL] [Abstract][Full Text] [Related]
26. The glucose-dependent insulinotropic polypeptide signaling axis in the central nervous system.
Adriaenssens AE; Gribble FM; Reimann F
Peptides; 2020 Mar; 125():170194. PubMed ID: 31697967
[TBL] [Abstract][Full Text] [Related]
27. Targeting glucose-dependent insulinotropic polypeptide receptor for neurodegenerative disorders.
Verma MK; Goel R; Krishnadas N; Nemmani KVS
Expert Opin Ther Targets; 2018 Jul; 22(7):615-628. PubMed ID: 29911915
[TBL] [Abstract][Full Text] [Related]
28. The role of GIP in α-cells and glucagon secretion.
El K; Campbell JE
Peptides; 2020 Mar; 125():170213. PubMed ID: 31785304
[TBL] [Abstract][Full Text] [Related]
29. Semiconducting polymer nano-radiopharmaceutical for combined radio-photothermal therapy of pancreatic tumor.
Shi X; Li Q; Zhang C; Pei H; Wang G; Zhou H; Fan L; Yang K; Jiang B; Wang F; Zhu R
J Nanobiotechnology; 2021 Oct; 19(1):337. PubMed ID: 34689758
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological characterization of mono-, dual- and tri-peptidic agonists at GIP and GLP-1 receptors.
Yuliantie E; Darbalaei S; Dai A; Zhao P; Yang D; Sexton PM; Wang MW; Wootten D
Biochem Pharmacol; 2020 Jul; 177():114001. PubMed ID: 32360365
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular biology of the GIP receptor.
Greenwell AA; Chahade JJ; Ussher JR
Peptides; 2020 Mar; 125():170228. PubMed ID: 31812593
[TBL] [Abstract][Full Text] [Related]
32. Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model.
Weaver RE; Donnelly D; Wabitsch M; Grant PJ; Balmforth AJ
Int J Obes (Lond); 2008 Nov; 32(11):1705-11. PubMed ID: 18779825
[TBL] [Abstract][Full Text] [Related]
33. TCF1 links GIPR signaling to the control of beta cell function and survival.
Campbell JE; Ussher JR; Mulvihill EE; Kolic J; Baggio LL; Cao X; Liu Y; Lamont BJ; Morii T; Streutker CJ; Tamarina N; Philipson LH; Wrana JL; MacDonald PE; Drucker DJ
Nat Med; 2016 Jan; 22(1):84-90. PubMed ID: 26642437
[TBL] [Abstract][Full Text] [Related]
34. Expression of glucose-dependent insulinotropic polypeptide and its receptor in the rat major salivary glands.
Privatananupunt J; Watari I; Podyma-Inoue KA; Kubono M; Ono T
Acta Histochem; 2014 May; 116(4):545-50. PubMed ID: 24360021
[TBL] [Abstract][Full Text] [Related]
35. Structural insights into hormone recognition by the human glucose-dependent insulinotropic polypeptide receptor.
Zhao F; Zhang C; Zhou Q; Hang K; Zou X; Chen Y; Wu F; Rao Q; Dai A; Yin W; Shen DD; Zhang Y; Xia T; Stevens RC; Xu HE; Yang D; Zhao L; Wang MW
Elife; 2021 Jul; 10():. PubMed ID: 34254582
[TBL] [Abstract][Full Text] [Related]
36. Internalization and desensitization of the human glucose-dependent-insulinotropic receptor is affected by N-terminal acetylation of the agonist.
Ismail S; Dubois-Vedrenne I; Laval M; Tikhonova IG; D'Angelo R; Sanchez C; Clerc P; Gherardi MJ; Gigoux V; Magnan R; Fourmy D
Mol Cell Endocrinol; 2015 Oct; 414():202-15. PubMed ID: 26225752
[TBL] [Abstract][Full Text] [Related]
37. Glucose-dependent insulinotropic peptide impairs insulin signaling via inducing adipocyte inflammation in glucose-dependent insulinotropic peptide receptor-overexpressing adipocytes.
Nie Y; Ma RC; Chan JC; Xu H; Xu G
FASEB J; 2012 Jun; 26(6):2383-93. PubMed ID: 22366643
[TBL] [Abstract][Full Text] [Related]
38. Glucose-dependent insulinotropic polypeptide enhances adipocyte development and glucose uptake in part through Akt activation.
Song DH; Getty-Kaushik L; Tseng E; Simon J; Corkey BE; Wolfe MM
Gastroenterology; 2007 Dec; 133(6):1796-805. PubMed ID: 18054552
[TBL] [Abstract][Full Text] [Related]
39. Resistin knockout mice exhibit impaired adipocyte glucose-dependent insulinotropic polypeptide receptor (GIPR) expression.
Kim SJ; Nian C; McIntosh CH
Diabetes; 2013 Feb; 62(2):471-7. PubMed ID: 23002036
[TBL] [Abstract][Full Text] [Related]
40. Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality.
Mieczkowska A; Irwin N; Flatt PR; Chappard D; Mabilleau G
Bone; 2013 Oct; 56(2):337-42. PubMed ID: 23851294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
